verified SJR 0,339 · Q3 • database Scopus / SJR indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Cardiovascular and Hematological Agents in Medicinal Chemistry

Cardiovascular and Hematological Agents in Medicinal Chemistry is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 44. It has an SJR impact factor of 0,339 and it has a best quartile of Q3. It has an SJR impact factor of 0,339.

ISSN: 1871-5257

Publisher: Bentham Science Publishers

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,339 Q3

H-index 44

Acceptance rate pie_chart

33%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,339

H-index

Docs (year)

Docs 3y

Total refs

2975

Cites 3y

Citable 3y

Cites/Doc 2y

1.5

Ref/Doc

59.5

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Calcium Channel Blockers -Benefits Upon Vascular Biology in Hypertensive Patients

What is the Evidence for the use of Adrenaline in the Treatment of Neonatal Hypotension?

Current Status of Rho-Associated Kinases (ROCKs) in Coronary Atherosclerosis and Vasospasm

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome

Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population

Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India

Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence

Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury

Cellular Mechanisms of the Protective Effect of Polyphenols on the Neurovascular Unit in Strokes

Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity

Cardiovascular Aspect of Beta-Thalassaemia

Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs

SHOW MORE ARTICLES

Cardiac Regeneration by Progenitor Cells: What Is It Known as and What Is It Still to Be Known as?

30 Years Lost in Anesthesia Theory

Blockade of the Renin-Angiotensin-Aldosterone System: Effects on Hypertensive Target Organ Damage

Beta-Blockers and Nitrates: Pharmacotherapy and Indications

Association of Lipoprotein-associated Phospholipase A2 Activity with Components of the Metabolic Syndrome in Apparently Healthy Boys

Aqueous Extract of Argania spinosa L. Fruits Ameliorates Diabetes in Streptozotocin-Induced Diabetic Rats

Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid Cancer

An Evidence-Based Systematic Review of Stevia by the Natural Standard Research Collaboration

Aliskiren: A New Drug for an Old Problem

Aeruginosin Analogs and Other Compounds with Rigid Bicyclic Structure as Potential Antithrombotic Agents

Acute Phase Proteins In Atherosclerosis (Acute Coronary Syndrome)

Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?

FAQs

Cardiovascular and Hematological Agents in Medicinal Chemistry has an SJR of 0,339 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cardiovascular and Hematological Agents in Medicinal Chemistry is 33%.

Cardiovascular and Hematological Agents in Medicinal Chemistry

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cardiovascular and Hematological Agents in Medicinal Chemistry?

What is the APC / publication cost?

What is the acceptance rate?